Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 10

Results: 25

Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03791-6

By:

Li, Wenjing;
You, Jianqing;
Xue, Haixiang;
Liu, Yi;
Chen, Junjun;
Zheng, Xiao;
Chen, Lujun;
Wu, Changping

Publication type:

Article

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03790-7

By:

Geva, Ravit;
Vieito, Maria;
Ramon, Jorge;
Perets, Ruth;
Pedregal, Manuel;
Corral, Elena;
Doger, Bernard;
Calvo, Emiliano;
Bardina, Jorge;
Garralda, Elena;
Brown, Regina J.;
Greger, James G.;
Wu, Shujian;
Steinbach, Douglas;
Yao, Tsun-Wen Sheena;
Cao, Yu;
Lauring, Josh;
Chaudhary, Ruchi;
Patel, Jaymala;
Patel, Bharvin

Publication type:

Article

Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13<sup>+</sup> CD4<sup>+</sup> T cell activation in oropharyngeal cancer: implications for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03789-0

By:

Yan, Shida;
Zhang, Xing;
Lin, Qiaohong;
Du, Mingyuan;
Li, Yiqi;
He, Shuai;
Chen, Jingtao;
Li, Xiyuan;
Bei, Jinxin;
Chen, Shuwei;
Song, Ming

Publication type:

Article

Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03788-1

By:

Duan, Rong;
Milton, Philip;
Sittplangkoon, Chutamath;
Liu, Xin;
Sui, Zhining;
Boyce, Brendan F.;
Yao, Zhenqiang

Publication type:

Article

Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03787-2

By:

Yang, Guozhen;
Hong, Yutong;
Zhang, Xiaomin;
Zeng, Chufeng;
Tan, Linyu;
Zhang, Xu

Publication type:

Article

The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03785-4

By:

Cho, Jaewon;
Tae, Nara;
Song, Yujeong;
Kim, Chae-Won;
Lee, Seung-Joo;
Ahn, Jae-Hee;
Lee, Kwang-Ho;
Lee, Byung-Hyun;
Kim, Byung Soo;
Chang, Sun-Young;
Kim, Dae Hee;
Ko, Hyun-Jeong

Publication type:

Article

Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03784-5

By:

Jiang, Jianyun;
Wu, Bin;
Sun, Ying;
Xiang, Jun;
Shen, Chunying;
He, Xiayun;
Ying, Hongmei;
Xia, Zuguang

Publication type:

Article

Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03782-7

By:

Park, Changhee;
Suh, Koung Jin;
Kim, Se Hyun;
Lee, Kyung-Hun;
Im, Seock-Ah;
Kim, Min Hwan;
Sohn, Joohyuk;
Jeong, Jae Ho;
Jung, Kyung Hae;
Lee, Kyoung Eun;
Park, Yeon Hee;
Kim, Hee-Jun;
Cho, Eun Kyung;
Choi, In Sil;
Noh, Seung-Jae;
Shin, Inkyung;
Cho, Dae-Yeon;
Kim, Jee Hyun

Publication type:

Article

CD27 signaling inhibits tumor growth and metastasis via CD8 + T cell-independent mechanisms in the B16-F10 melanoma model.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03780-9

By:

Puppala, Eswara Rao;
Wu, Long;
Fan, Xiaoxuan;
Cao, Xuefang

Publication type:

Article

Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03779-2

By:

Xu, Haonan;
Russell, Shannon Nicole;
Steiner, Katherine;
O’Neill, Eric;
Jones, Keaton Ian

Publication type:

Article

Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03778-3

By:

Saunderson, S. C.;
Halpin, J. C.;
Tan, G. M. Y.;
Shrivastava, P.;
McLellan, A. D.

Publication type:

Article

ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03777-4

By:

Kim, Nam-Hoon;
Lee, Jihyun;
Kim, Seung-Hyun;
Kang, Seong-Ho;
Bae, Sowon;
Yu, Chan-Hee;
Seo, Jeongmin;
Kim, Hun-Taek

Publication type:

Article

GP100 expression is variable in intensity in melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03776-5

By:

Mann, Jacqueline E.;
Hasson, Nitzan;
Su, David G.;
Adeniran, Adebowale J.;
Smalley, Keiran S. M.;
Djureinovic, Dijana;
Jilaveanu, Lucia B.;
Schoenfeld, David A.;
Kluger, Harriet M.

Publication type:

Article

Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03775-6

By:

Muddasani, Ramya;
Talwar, Neel;
Mambetsariev, Isa;
Fricke, Jeremy;
Lin, Mercury;
Schmolze, Daniel;
Yue, Andrew;
Rizvi, Amna;
Salgia, Ravi

Publication type:

Article

Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03774-7

By:

Guo, Guangzhong;
Zhang, Ziyue;
Zhang, Jiubing;
Wang, Dayang;
Xu, Sensen;
Liu, Guanzheng;
Gao, Yushuai;
Mei, Jie;
Yan, Zhaoyue;
Zhao, Ruijiao;
Wang, Meiyun;
Li, Tianxiao;
Bu, Xingyao

Publication type:

Article

TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03773-8

By:

Perales, Oscar;
Jilaveanu, Lucia;
Adeniran, Adebowale;
Su, David G.;
Hurwitz, Michael;
Braun, David A.;
Kluger, Harriet M.;
Schoenfeld, David A.

Publication type:

Article

First-line treatment with KN046, chemotherapy and palliative radiotherapy for advanced esophageal squamous cell carcinoma: an open-label, dose escalation, and dose expansion phase Ib trial.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03769-4

By:

Zhao, Qi;
Su, Xi;
Xue, Jiao;
Liu, Yandong;
Zhu, Jiaxing;
Cai, Xuwei;
Qin, Songbing

Publication type:

Article

Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03744-z

By:

Wang, Qin;
Tong, Fan;
Qiao, Li;
Qi, Liang;
Sun, Yi;
Zhu, Yahui;
Ni, Jiayao;
Liu, Juan;
Kong, Weiwei;
Liu, Baorui;
Du, Juan

Publication type:

Article

NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03795-2

By:

Herault, Aurelie;
Mak, Judy;
de la Cruz-Chuh, Josefa;
Dillon, Michael A.;
Ellerman, Diego;
Go, MaryAnn;
Cosino, Ely;
Clark, Robyn;
Carson, Emily;
Yeung, Stacey;
Pichery, Melanie;
Gador, Mylène;
Chiang, Eugene Y.;
Wu, Jia;
Liang, Yuxin;
Modrusan, Zora;
Gampa, Gautham;
Sudhamsu, Jawahar;
Kemball, Christopher C.;
Cheung, Victoria

Publication type:

Article

DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03786-3

By:

Tasiheng, Yesiboli;
Lin, Xuan;
Wang, Xu;
Zou, Xuan;
Chen, Yusheng;
Yan, Yu;
Ma, Mingjian;
Dai, Zhengjie;
Yu, Xianjun;
Cheng, He;
Liu, Chen

Publication type:

Article

Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03794-3

By:

Guo, Cuicui;
Dai, Xiaodong;
Du, Yulei;
Xiong, Xiumei;
Gui, Xun

Publication type:

Article

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03772-9

By:

Albarrán, Víctor;
Guerrero, Patricia;
de Quevedo, Coral García;
González, Carlos;
Chamorro, Jesús;
Rosero, Diana Isabel;
Moreno, Jaime;
Calvo, Juan Carlos;
de Aguado, Patricia Pérez;
Alía, Víctor;
Sotoca, Pilar;
Barrill, Ana María;
Román, María San;
Álvarez-Ballesteros, Pablo;
Serrano, Juan José;
Soria, Ainara;
Olmedo, María Eugenia;
Saavedra, Cristina;
Cortés, Alfonso;
Gómez, Ana

Publication type:

Article

Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03767-6

By:

Tian, Yan;
Liu, Chao;
Yang, Wenhui;
Li, Xiaohui;
Zhang, Min;
Xiong, Yan;
Ren, Xueying;
Ma, Zhiguo;
Jin, Xuan;
Wu, Yanping;
Dong, Xin;
Hu, Nanlin;
Xie, Zhijun;
Qin, Yong;
Wu, Shikai

Publication type:

Article

Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03762-x

By:

Cai, Siqi;
Yang, Guanqun;
Hu, Mengyu;
Li, Chaozhuo;
Yang, Liying;
Zhang, Wei;
Sun, Jujie;
Sun, Fenghao;
Xing, Ligang;
Sun, Xiaorong

Publication type:

Article

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03756-9

By:

Wu, Huantong;
Xu, Zhuofan;
Qi, Maoyang;
Liu, Penghao;
Zhang, Boyan;
Wang, Zhenglin;
Chen, Ge;
Liu, Xiaohai;
Liu, Junqi;
Wei, Wei;
Duan, Wanru;
Chen, Zan

Publication type:

Article